Advances in the relationship between microRNA-483 and digestive system tumors
Wei Zhou(Broad Institute), Qiong Zhang(Huazhong University of Science and Technology), Bo Lyu(Chinese Academy of Sciences), Hongwei Zhang(University of Massachusetts Chan Medical School), Wanli Yang(National Clinical Research Center for Digestive Diseases), Shuao Xiao(Xijing Hospital), Xuewen Yang(Harbin Medical University), Xiao Lian, Lei Cai(Chongqing University)
Zhōnghuá xiāohuà wàikē zázhì/Zhonghua xiaohua waike zazhi
May 20, 2018
Cited by 0
Related Papers
Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial
|The Lancet Oncology|2015|1.6k
miRNA-223 Promotes Gastric Cancer Invasion and Metastasis by Targeting Tumor Suppressor EPB41L3
|Molecular Cancer Research|2011|361
Targeting p21-activated kinase 1 (PAK1) to induce apoptosis of tumor cells
|Proceedings of the National Academy of Sciences|2011|256
Global CNS Transduction of Adult Mice by Intravenously Delivered rAAVrh.8 and rAAVrh.10 and Nonhuman Primates by rAAVrh.10
|Molecular Therapy|2014|211
SR-BI protects against endotoxemia in mice through its roles in glucocorticoid production and hepatic clearance
|Journal of Clinical Investigation|2008|170